Roche Holding AG (RHO)
XHAN
Closed
Aug 25, 2026
Day's Range
400.6052 wk Range
281.00Overview - RHO - Roche Holding AG
Key Statistics
Valuation
Enterprise Value
27.60B
P/E (Trailing)
‪25.06‬
EV / EBITDA
‪1.24‬
Profitability
Profit Margin
‪73.72%‬
Operating Margin
‪28.91%‬
Return on Assets
‪12.79%‬
Return on Equity
‪34.00%‬
Ownership
Shares Outstanding
796.76M
Price stats
50-Day Avg
‪375.73‬
200-Day Avg
‪368.81‬
Dividends
Frequency
Annual
Peers - RHO - Roche Holding AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XHAN.
- RHOXHANRoche Holding AG+25.68%52-week change23.78P/E (Trailing)‪73.72%‬Profit Margin
- NOVXHANNov Inc.+40.08%52-week change79.84P/E (Trailing)‪1.04%‬Profit Margin
- BAYNXHANBayer AG+41.84%52-week change-13.17P/E (Trailing)‪58.75%‬Profit Margin
- 6MKXHANMerck & Co., Inc.+40.00%52-week change15.37P/E (Trailing)‪74.80%‬Profit Margin
- AMGXHANAmgen Inc.+35.39%52-week change26.72P/E (Trailing)‪67.24%‬Profit Margin
- IDPXHANBiogen Inc.+33.96%52-week change19.46P/E (Trailing)‪75.69%‬Profit Margin
- JNJXHANJohnson & Johnson+30.51%52-week change17.34P/E (Trailing)‪67.87%‬Profit Margin
Profile Summary - RHO - Roche Holding AG
About
Roche Holding AG is a Swiss multinational holding company and one of the world's largest biotech firms, overseeing the operations of F. Hoffmann-La Roche AG, a leading provider of pharmaceuticals and in-vitro diagnostics. Founded in 1896 and headquartered in Basel, it drives innovation across major disease areas…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
